SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-038720
Filing Date
2023-02-14
Accepted
2023-02-14 14:31:54
Documents
2
Group Members
JOSEPH EDELMANPERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d444696dsc13ga.htm SC 13G/A 58679
2 EX-99.1 d444696dex991.htm EX-99.1 3954
  Complete submission text file 0001193125-23-038720.txt   64273
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Subject) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83043 | Film No.: 23627231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A